首页 > 市场调查报告书 > 医疗设备

生技设备

市场调查报告书

商品编码

1593524

细胞分离市场规模、份额和成长分析（按产品、按细胞类型、按细胞来源、按技术、按应用、按地区）：产业预测（2024-2031）

Cell Isolation Market Size, Share, Growth Analysis, By Product (Consumables, Instruments), By Cell Type (Human Cells, Animal Cells), By Cell Source, By Technique, By Application, By Region - Industry Forecast 2024-2031

出版日期: 2024年11月09日 | 出版商:

SkyQuest | 英文 188 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球细胞分离市场规模估值为42亿美元，从2023年的47.4亿美元成长到2031年的124.2亿美元，在预测期间（2024-2031）预计复合年增长率为12.80%。

全球细胞分离市场由于其在生技药品开发、治疗性蛋白质合成、内部分析和研究等应用中的重要作用而正在经历强劲增长。癌症和 COVID-19 等慢性疾病的盛行率上升和成本上升，加上政府加强生物技术的倡议，是关键的成长决定因素。 NanoString Technologies、Levitas Bio 和 Bionano Genomics 等公司正在改进其製造流程并扩大其产品范围，以便为高级应用领域实现精确的细胞选择。 COVID-19 大流行进一步加速了新疗法和诊断辅助手段的研究，2020 年 8 月美国紧急支出法案等倡议正在推动对细胞分离设备的需求。随着专科药物和学名药呈指数级增长，对生物製药的依赖日益增加将推动市场的发展。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲
中东和非洲 (MEA)
- 波湾合作理事会(GCC) 国家
- 南非
- 其他中东/非洲

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

丹纳赫公司（美国）
默克公司（德国）
赛默飞世尔科技公司（美国）
BD（贝克顿迪金森公司）（美国）
赛多利斯股份公司（德国）
安捷伦科技公司（美国）
Bio-Rad 实验室公司（美国）
凯杰（荷兰）
F. Hoffmann-La Roche Ltd.（瑞士）
復兴（美国）
龙沙（瑞士）
Bio-Techne（美国）
泰尔茂株式会社（日本）
Miltenyi Biotec（德国）
Takara Bio Inc.（日本）
金斯瑞（中国）
标准生物工具（美国）
Alfa Laval (Sweden)
Promega 公司（美国）
Cell Signaling Technology, Inc.（美国）
米卡雷奥公司（美国）
应用细胞公司（美国）
干细胞技术（加拿大）
创意生物阵列（美国）
Proteintech Group, Inc.（美国）
Magbio Genomics, Inc.（美国）
生命科学学院（美国）
Pluriselect Life Science Ug (Haftungsbeschrankt) & Co. KG（德国）
发明生物技术公司（美国）

简介目录

Product Code: SQMIG35H2298

Global Cell Isolation Market size was valued at USD 4.2 billion in 2022 and is poised to grow from USD 4.74 billion in 2023 to USD 12.42 billion by 2031, growing at a CAGR of 12.80% during the forecast period (2024-2031).

The global cell isolation market is witnessing robust growth driven by its critical role in applications such as biologics development, therapeutic protein synthesis, internal analysis, and research. Rising prevalence and costs of chronic diseases like cancer and COVID-19, coupled with government initiatives to bolster biotechnology, are key growth determinants. Companies like NanoString Technologies, Levitas Bio, and Bionano Genomics are enhancing their manufacturing processes and expanding product offerings, enabling precise cell selection for advanced applications. The COVID-19 pandemic further accelerated research in new treatment and diagnostic aids, with initiatives like the U.S. emergency spending bill of August 2020 boosting demand for cell isolation equipment. Growing reliance on biopharmaceuticals fuels the market as specialty and generic medicines expand exponentially.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Isolation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Isolation Market Segmental Analysis

Global Cell Isolation Market is segmented by Product, Cell Type, Cell Source, Technique, Application, End User, and region. Based on Product, the market is segmented into Consumables, and Instruments. Based on Cell Type, the market is segmented into Human Cells, and Animal Cells. Based on Cell Source, the market is segmented into Adipose Tissue, Bone Marrow, Cord Blood/Embryonic Stem Cells, and Other Cell Sources. Based on Technique, the market is segmented into Centrifugation-Based Cell Isolation, Surface Marker-Based Cell Isolation, and Filtration-Based Cell Isolation. Based on Application, the market is segmented into Biomolecule Isolation, Cancer Research, Stem Cell Research, Tissue, Regeneration & Regenerative Medicine, In Vitro Diagnostics, and Other Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Laboratories, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Cell Isolation Market

One of the key drivers of the global cell isolation market is the rising prevalence of chronic diseases, particularly cancer. As cancer cases surge globally, there is a growing demand for advanced research and treatment solutions. Cell isolation plays a pivotal role in cancer research by enabling the study of specific cell types, facilitating the development of targeted therapies and personalized medicine. Isolated cells provide critical insights into tumor biology, drug resistance, and immune responses, driving the creation of more effective treatments. Additionally, the increasing adoption of advanced therapies, such as immunotherapy, further boosts the demand for cell isolation techniques. This trend underscores the importance of innovation in the cell isolation market, as research institutes and biotech firms intensify their efforts to combat chronic diseases.

Restraints in the Global Cell Isolation Market

A significant restraint in the global cell isolation market is the high cost of specialized equipment and technologies required for isolating specific cell types. Advanced tools such as flow cytometers, centrifuges, and magnetic-activated cell sorting (MACS) systems are costly, limiting access, particularly for smaller research institutions and laboratories. Additionally, the ongoing expenses related to reagents, as well as the need for highly skilled personnel to operate the equipment, further elevate the financial burden. These factors may restrict the widespread adoption and utilization of advanced cell isolation techniques, particularly in regions with limited financial resources or budget constraints.

Market Trends of the Global Cell Isolation Market

A key trend shaping the global cell isolation market is the growing adoption of microfluidics technology. This innovative approach utilizes small quantities of fluids through microchannels to precisely separate cells based on characteristics such as length, shape, and other biological properties. Microfluidics is gaining significant traction for its ability to efficiently isolate rare cells, such as circulating tumor cells (CTCs) and stem cells, from complex biological samples. Its enhanced precision and performance, coupled with cost-effective processing that minimizes reagent usage, make it a highly attractive solution for both research and medical applications. As a result, microfluidics is poised to revolutionize cell isolation, offering improved accuracy and efficiency in diverse clinical and research settings.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Technology Analysis
Pricing Analysis
Value Chain Analysis
Patent Analysis
Supply Chain Analysis
Regulatory Landscape
Customer & Buying Criteria Analysis

Cell Isolation Market by Product

Market Overview
Consumables
- Reagents, Kits, Media, And Sera
- Beads
- Magnetic Beads
- Fluorescent Beads
- Disposables
Instruments
- Centrifuges
- Cell Sorters
- Magnetic-Activated Cell Separator Systems
- Filtration Systems

Cell Isolation Market by Cell Type

Market Overview
Human Cells
- Differentiated Cells
- Stem Cells
Animal Cells

Cell Isolation Market by Cell Source

Market Overview
Adipose Tissue
Bone Marrow
Cord Blood/Embryonic Stem Cells
Other Cell Sources

Cell Isolation Market by Technique

Market Overview
Centrifugation-Based Cell Isolation
Surface Marker-Based Cell Isolation
Filtration-Based Cell Isolation

Cell Isolation Market by Application

Market Overview
Biomolecule Isolation
Cancer Research
Stem Cell Research
Tissue Regeneration & Regenerative Medicine
In Vitro Diagnostics
Other Applications

Cell Isolation Market by End User

Market Overview
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Hospitals & Diagnostic Laboratories
Other End Users

Cell Isolation Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGAA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD (Becton, Dickinson and Company) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Revvity (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miltenyi Biotec (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genscript (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Standard Biotools (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alfa Laval (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cell Signaling Technology, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Micareo Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Applied Cells Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stemcell Technologies (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Bioarray (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Proteintech Group, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Magbio Genomics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Akadeum Life Sciences (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pluriselect Life Science Ug (Haftungsbeschrankt) & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Invent Biotechnologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments